Effect of Augmented Antimicrobial Prophylaxis and Rectal Swab Culture-guided Targeted Prophylaxis on the Risk of Sepsis Following Transrectal Prostate Biopsy

被引:17
作者
Hadjipavlou, Marios [1 ]
Eragat, Mazin [1 ]
Kenny, Charlotte [1 ]
Pantelidou, Maria [1 ,2 ]
Mulhem, Waseem [1 ]
Wood, Chris [3 ]
Dall'Antonia, Martino [2 ]
Hammadeh, Mohamed Y. [1 ]
机构
[1] Queen Elizabeth Hosp, Dept Urol, London SE18 4QH, England
[2] Queen Elizabeth Hosp, Dept Microbiol, London, England
[3] Queen Elizabeth Hosp, Pharm Dept, London, England
来源
EUROPEAN UROLOGY FOCUS | 2020年 / 6卷 / 01期
关键词
Transrectal prostate biopsy; Sepsis; Rectal swab; Antibiotic resistance; Antibiotic prophylaxis; REDUCING INFECTION-RATES; HOSPITAL ADMISSIONS; ESCHERICHIA-COLI; ANTIBIOTIC-PROPHYLAXIS; ERTAPENEM PROPHYLAXIS; COMPLICATIONS; FOSFOMYCIN; PREVALENCE; RESISTANCE; IMPACT;
D O I
10.1016/j.euf.2018.06.016
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: Sepsis is a severe complication following transrectal ultrasound-guided prostate biopsy (TRUSPBx). Ciprofloxacin is commonly used for prophylaxis; however, there is an increasing incidence of resistant enteric organisms worldwide. Objective: To investigate the effect of a targeted prophylactic antimicrobial regimen based on rectal swab cultures in reducing the rate of sepsis. Design, setting, and participants: A total of 1012 patients were included. Group A (609 patients) received an empirical prophylactic antimicrobial regimen of gentamicin, metronidazole, and ciprofloxacin. Targeted antimicrobial prophylaxis was introduced due to significant ciprofloxacin and gentamicin resistance in patients admitted with sepsis following TRUSPBx. The remaining 403 patients (Group B) had rectal swab cultures performed prior to biopsy. Patients with organisms resistant to ciprofloxacin or gentamicin received a targeted prophylaxis regimen of fosfomycin, amikacin, and metronidazole. Outcome measurements and statistical analysis: We retrospectively collected and analysed data on sepsis and bacteraemia for all patients as well as data on rectal swab culture, recent foreign travel, and recent antibiotic use for patients in Group B. Results and limitations: In group A, 12 (2.0%) patients developed sepsis following TRUSPBx, while in group B, 9 (2.2%) patients developed sepsis despite targeted prophylaxis (p = 0.82). Patients with ciprofloxacin-resistant rectal flora had a significantly higher rate of sepsis (9.1% vs 1.1%; p = 0.003). [13TD$DIF]. There was a reduction in patients admitted with bacteraemia and severe sepsis between group A(1.2%) and group B(0.3%) which did not reach statistical significance p = 0.16). In group B, 55 of 403 (13.6%) patients had ciprofloxacin-resistant rectal flora, while 66 (16.4%) had organisms resistant to both ciprofloxacin and gentamicin. A recent foreign travel history was associated with an increased incidence of ciprofloxacin-resistant rectal flora (23.6% vs 10.8%; p = 0.007). The main limitations of our study include its retrospective nature and potential under-reporting of less severe infectious complications. Conclusions: Rectal swab cultures identify patients with ciprofloxacin-resistant rectal flora who have an eight-fold risk of sepsis. Targeted antimicrobial prophylaxis may not be beneficial in reducing the sepsis rate when compared with augmented empirical prophylaxis. In an era of increasing antimicrobial resistance, transperineal prostate biopsies should be considered to reduce the risk of infective complications. Patient summary: Performing rectal swab culture prior to transrectal prostate biopsy can help identify patients at risk of developing sepsis despite targeted prophylactic antibiotics. (C) 2018 European Association of Urology. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:95 / 101
页数:7
相关论文
共 42 条
  • [1] Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study
    Ahmed, Hashim U.
    Bosaily, Ahmed El-Shater
    Brown, Louise C.
    Gabe, Rhian
    Kaplan, Richard
    Parmar, Mahesh K.
    Collaco-Moraes, Yolanda
    Ward, Katie
    Hindley, Richard G.
    Freeman, Alex
    Kirkham, Alex P.
    Oldroyd, Robert
    Parker, Chris
    Emberton, Mark
    [J]. LANCET, 2017, 389 (10071) : 815 - 822
  • [2] PENETRATION OF TEMOCILLIN INTO PROSTATIC TISSUE AFTER INTRAVENOUS DOSING
    BAERT, L
    ASWARIE, H
    VERBIST, L
    HORTON, R
    [J]. ACTA CLINICA BELGICA, 1989, 44 (05): : 358 - 359
  • [3] Comment on: The national burden of infections after prostate biopsy in England and Wales: a wake-up call for better prevention
    Balakrishnan, Indran
    Smith, Gillian
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2013, 68 (10) : 2418 - 2419
  • [4] Magnetic resonance imaging targeted transperineal prostate biopsy: a local anaesthetic approach
    Bass, E. J.
    Donaldson, I. A.
    Freeman, A.
    Jameson, C.
    Punwani, S.
    Moore, C.
    Arya, M.
    Emberton, M.
    Ahmed, H. U.
    [J]. PROSTATE CANCER AND PROSTATIC DISEASES, 2017, 20 (03) : 311 - 317
  • [5] Routine Ertapenem Prophylaxis for Transrectal Ultrasound Guided Prostate Biopsy does Not Select for Carbapenem Resistant Organisms: A Prospective Cohort Study
    Bloomfield, Maxim G.
    Page, Matthew J.
    McLachlan, Alice G.
    Studd, Rodney C.
    Blackmore, Timothy K.
    [J]. JOURNAL OF UROLOGY, 2017, 198 (02) : 362 - 367
  • [6] One preoperative dose randomized against 3-day antibiotic prophylaxis for transrectal ultrasonography-guided prostate biopsy
    Briffaux, Raphael
    Coloby, Patrick
    Bruyere, Franck
    Ouaki, Frederic
    Pires, Christophe
    Dore, Bertrand
    Irani, Jacques
    [J]. BJU INTERNATIONAL, 2009, 103 (08) : 1069 - 1073
  • [7] Antimicrobial prophylaxis for transrectal ultrasound-guided prostate biopsy: fosfomycin trometamol, an attractive alternative
    Cai, Tommaso
    Gallelli, Luca
    Cocci, Andrea
    Tiscione, Daniele
    Verze, Paolo
    Lanciotti, Michele
    Vanacore, Davide
    Rizzo, Michele
    Gacci, Mauro
    Saleh, Omar
    Malossini, Gianni
    Liguori, Giovanni
    Trombetta, Carlo
    Rocco, Damiano
    Palmieri, Alessandro
    Bartoletti, Riccardo
    Carini, Marco
    Wagenlehner, Florian M. E.
    Naber, Kurt
    Mirone, Vincenzo
    Johansen, Truls E. Bjerklund
    [J]. WORLD JOURNAL OF UROLOGY, 2017, 35 (02) : 221 - 228
  • [8] Ready for a world without antibiotics? The Pensieres Antibiotic Resistance Call to Action
    Carlet, Jean
    Jarlier, Vincent
    Harbarth, Stephan
    Voss, Andreas
    Goossens, Herman
    Pittet, Didier
    [J]. ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL, 2012, 1
  • [9] FOSFOMYCIN FOR ANTIBIOTIC PROPHYLAXIS PRIOR TO TRANSRECTAL ULTRASOUND-GUIDED PROSTATE BIOPSY
    Colhoun, Andrew
    Sulek, Jay
    McDowell, Zachary
    Climo, Michael
    Grob, B. Mayer
    [J]. JOURNAL OF UROLOGY, 2015, 193 (04) : E286 - E286
  • [10] Significant ecological impact on the progression of fluoroquinolone resistance in Escherichia coli with increased community use of moxifloxacin, levofloxacin and amoxicillin/clavulanic acid
    Cuevas, Oscar
    Oteo, Jesus
    Lazaro, Edurne
    Aracil, Belen
    de Abajo, Francisco
    Garcia-Cobos, Silvia
    Ortega, Adriana
    Campos, Jose
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2011, 66 (03) : 664 - 669